Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Right ventricular function correlates of right atrial strain in pulmonary hypertension: a combined cardiac magnetic resonance and conductance catheter study.

Tello K, Dalmer A, Vanderpool RR, Ghofrani HA, Naeije R, Roller F, Seeger W, Wiegand M, Gall H, Richter MJ.

Am J Physiol Heart Circ Physiol. 2019 Nov 22. doi: 10.1152/ajpheart.00485.2019. [Epub ahead of print]

PMID:
31756118
2.

Looking backwards: is it time to assess veno-atrial interactions in pulmonary arterial hypertension?

Pugliese S, Vanderpool RR.

Eur Respir J. 2019 Oct 17;54(4). pii: 1901598. doi: 10.1183/13993003.01598-2019. Print 2019 Oct. No abstract available.

PMID:
31624132
3.

MicroRNA-mediated Downregulation of K+ Channels in Pulmonary Arterial Hypertension.

Babicheva A, Ayon RJ, Zhao T, Ek Vitorin JF, Pohl NM, Yamamura A, Yamamura H, Quinton BA, Ba M, Wu L, Ravellette KS, Rahimi S, Balistrieri F, Harrington A, Vanderpool RR, Thistlethwaite PA, Makino A, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2019 Sep 25. doi: 10.1152/ajplung.00010.2019. [Epub ahead of print]

PMID:
31553627
4.

Dynamic right ventricular-pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension.

Singh I, Rahaghi FN, Naeije R, Oliveira RKF, Vanderpool RR, Waxman AB, Systrom DM.

Pulm Circ. 2019 Jul-Sep;9(3):2045894019862435. doi: 10.1177/2045894019862435.

5.

EXPRESS: Surfing the Right Ventricular Pressure Waveform: Methods to assess Global, Systolic and Diastolic RV Function from a Clinical Right Heart Catheterization.

Vanderpool RR, Puri R, Osorio A, Wickstrom K, Desai A, Black S, Garcia JGN, Yuan J, Rischard F.

Pulm Circ. 2019 Apr 29:2045894019850993. doi: 10.1177/2045894019850993. [Epub ahead of print] No abstract available.

PMID:
31032737
6.

EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Kiely DG, Levin D, Hassoun P, Ivy DD, Jone PN, Bwika J, Kawut SM, Lordan J, Lungu A, Mazurek J, Moledina S, Olschewski H, Peacock A, Puri GD, Rahaghi F, Schafer M, Schiebler M, Screaton N, Tawhai M, Van Beek EJ, Vonk-Noordegraaf A, Vanderpool RR, Wort J, Zhao L, Wild J, Vogel-Claussen J, Swift AJ.

Pulm Circ. 2019 Mar 18:2045894019841990. doi: 10.1177/2045894019841990. [Epub ahead of print] No abstract available.

7.

Longitudinal Evaluation of Pulmonary Arterial Hypertension in a Rhesus Macaque (Macaca mulatta) Model of HIV Infection.

Tarantelli RA, Schweitzer F, Simon MA, Vanderpool RR, Christman I, Rayens E, Kling HM, Zullo T, Carney JP, Lopresti BJ, Bertero T, Chan SY, Norris KA.

Comp Med. 2018 Dec 1;68(6):461-473. doi: 10.30802/AALAS-CM-18-000012. Epub 2018 Dec 12.

8.

Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension.

Maestas T, Hansen LM, Vanderpool RR, Desai AA, Airhart S, Knapp SM, Cohen A, Feldman J, Rischard FP.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018797270. doi: 10.1177/2045894018797270. Epub 2018 Aug 20.

9.

What Causes Pulmonary Arterial Hypertension in Down Syndrome With Congenital Heart Disease?

Hosokawa S, Vanderpool RR, Ishii T, Nishiyama M, Doi S.

Circ J. 2018 May 25;82(6):1513-1514. doi: 10.1253/circj.CJ-18-0471. Epub 2018 May 12. No abstract available.

10.

Metformin Therapy for Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction versus Pulmonary Arterial Hypertension.

Goncharov DA, Goncharova EA, Tofovic SP, Hu J, Baust JJ, Pena AZ, Ray A, Rode A, Vanderpool RR, Mora AL, Gladwin MT, Lai YC.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):681-684. doi: 10.1164/rccm.201801-0022LE. No abstract available.

11.

Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.

Vanderpool RR, Saul M, Nouraie M, Gladwin MT, Simon MA.

JAMA Cardiol. 2018 Apr 1;3(4):298-306. doi: 10.1001/jamacardio.2018.0128. Erratum in: JAMA Cardiol. 2018 Jul 1;3(7):665.

12.

Hematocrit-corrected Pulmonary Vascular Resistance.

Vanderpool RR, Naeije R.

Am J Respir Crit Care Med. 2018 Aug 1;198(3):305-309. doi: 10.1164/rccm.201801-0081PP. Review. No abstract available.

PMID:
29537290
13.

Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.

Whitaker ME, Nair V, Sinari S, Dherange PA, Natarajan B, Trutter L, Brittain EL, Hemnes AR, Austin ED, Patel K, Black SM, Garcia JGN, Yuan Md PhD JX, Vanderpool RR, Rischard F, Makino A, Bedrick EJ, Desai AA.

Am J Med. 2018 Jun;131(6):702.e7-702.e13. doi: 10.1016/j.amjmed.2017.12.046. Epub 2018 Feb 5.

14.

Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.

Potoka KP, Wood KC, Baust JJ, Bueno M, Hahn SA, Vanderpool RR, Bachman T, Mallampalli GM, Osei-Hwedieh DO, Schrott V, Sun B, Bullock GC, Becker-Pelster EM, Wittwer M, Stampfuss J, Mathar I, Stasch JP, Truebel H, Sandner P, Mora AL, Straub AC, Gladwin MT.

Am J Respir Cell Mol Biol. 2018 May;58(5):636-647. doi: 10.1165/rcmb.2017-0292OC.

15.

Is p38 MAPK a Dark Force in Right Ventricular Hypertrophy and Failure in Pulmonary Arterial Hypertension?

Vanderpool RR, Tang H, Rischard F, Yuan JX.

Am J Respir Cell Mol Biol. 2017 Nov;57(5):506-508. doi: 10.1165/rcmb.2017-0197ED. No abstract available.

16.

Biomechanical and Hemodynamic Measures of Right Ventricular Diastolic Function: Translating Tissue Biomechanics to Clinical Relevance.

Jang S, Vanderpool RR, Avazmohammadi R, Lapshin E, Bachman TN, Sacks M, Simon MA.

J Am Heart Assoc. 2017 Sep 12;6(9). pii: e006084. doi: 10.1161/JAHA.117.006084.

17.

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

Tang H, Vanderpool RR, Wang J, Yuan JX.

Pulm Circ. 2017 Jul-Sep;7(3):569-571. doi: 10.1177/2045893217728261. No abstract available.

18.

How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension.

Vanderpool RR, Desai AA, Knapp SM, Simon MA, Abidov A, Yuan JX, Garcia JGN, Hansen LM, Knoper SR, Naeije R, Rischard FP.

Eur Respir J. 2017 Aug 24;50(2). pii: 1700764. doi: 10.1183/13993003.00764-2017. Print 2017 Aug. No abstract available.

19.

Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.

Meng Q, Lai YC, Kelly NJ, Bueno M, Baust JJ, Bachman TN, Goncharov D, Vanderpool RR, Radder JE, Hu J, Goncharova E, Morris AM, Mora AL, Shapiro SD, Gladwin MT.

Am J Respir Cell Mol Biol. 2017 Apr;56(4):497-505. doi: 10.1165/rcmb.2016-0177OC.

20.

Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor Receptor.

Kelly NJ, Radder JE, Baust JJ, Burton CL, Lai YC, Potoka KC, Agostini BA, Wood JP, Bachman TN, Vanderpool RR, Dandachi N, Leme AS, Gregory AD, Morris A, Mora AL, Gladwin MT, Shapiro SD.

Am J Respir Cell Mol Biol. 2017 Apr;56(4):488-496. doi: 10.1165/rcmb.2016-0176OC.

21.

Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction.

Simon MA, Vanderpool RR, Nouraie M, Bachman TN, White PM, Sugahara M, Gorcsan J 3rd, Parsley EL, Gladwin MT.

JCI Insight. 2016 Nov 3;1(18):e89620. doi: 10.1172/jci.insight.89620.

22.

TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.

Rogers NM, Sharifi-Sanjani M, Yao M, Ghimire K, Bienes-Martinez R, Mutchler SM, Knupp HE, Baust J, Novelli EM, Ross M, St Croix C, Kutten JC, Czajka CA, Sembrat JC, Rojas M, Labrousse-Arias D, Bachman TN, Vanderpool RR, Zuckerbraun BS, Champion HC, Mora AL, Straub AC, Bilonick RA, Calzada MJ, Isenberg JS.

Cardiovasc Res. 2017 Jan;113(1):15-29. doi: 10.1093/cvr/cvw218. Epub 2016 Oct 13.

23.

Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension.

Bertero T, Oldham WM, Cottrill KA, Pisano S, Vanderpool RR, Yu Q, Zhao J, Tai Y, Tang Y, Zhang YY, Rehman S, Sugahara M, Qi Z, Gorcsan J 3rd, Vargas SO, Saggar R, Saggar R, Wallace WD, Ross DJ, Haley KJ, Waxman AB, Parikh VN, De Marco T, Hsue PY, Morris A, Simon MA, Norris KA, Gaggioli C, Loscalzo J, Fessel J, Chan SY.

J Clin Invest. 2016 Sep 1;126(9):3313-35. doi: 10.1172/JCI86387. Epub 2016 Aug 22.

24.

Simple functional imaging of the right ventricle in pulmonary hypertension: Can right ventricular ejection fraction be improved?

Vanderpool RR, Rischard F, Naeije R, Hunter K, Simon MA.

Int J Cardiol. 2016 Nov 15;223:93-94. doi: 10.1016/j.ijcard.2016.08.138. Epub 2016 Aug 8. No abstract available.

25.

Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.

Brewis MJ, Bellofiore A, Vanderpool RR, Chesler NC, Johnson MK, Naeije R, Peacock AJ.

Int J Cardiol. 2016 Sep 1;218:206-211. doi: 10.1016/j.ijcard.2016.05.015. Epub 2016 May 13.

26.

SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.

Lai YC, Tabima DM, Dube JJ, Hughan KS, Vanderpool RR, Goncharov DA, St Croix CM, Garcia-Ocaña A, Goncharova EA, Tofovic SP, Mora AL, Gladwin MT.

Circulation. 2016 Feb 23;133(8):717-31. doi: 10.1161/CIRCULATIONAHA.115.018935. Epub 2016 Jan 26.

27.

Progress in Pulmonary Hypertension with Left Heart Failure. Beyond New Definitions and Acronyms.

Vanderpool RR, Naeije R.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1152-4. doi: 10.1164/rccm.201507-1509ED. No abstract available.

PMID:
26568239
28.

RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension.

Vanderpool RR, Pinsky MR, Naeije R, Deible C, Kosaraju V, Bunner C, Mathier MA, Lacomis J, Champion HC, Simon MA.

Heart. 2015 Jan;101(1):37-43. doi: 10.1136/heartjnl-2014-306142. Epub 2014 Sep 11.

29.

Dobutamine stress echocardiography for the assessment of pressure-flow relationships of the pulmonary circulation.

Lau EMT, Vanderpool RR, Choudhary P, Simmons LR, Corte TJ, Argiento P, D'Alto M, Naeije R, Celermajer DS.

Chest. 2014 Oct;146(4):959-966. doi: 10.1378/chest.13-2300.

PMID:
24626933
30.

Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences.

Argiento P, Vanderpool RR, Mulè M, Russo MG, D'Alto M, Bossone E, Chesler NC, Naeije R.

Chest. 2012 Nov;142(5):1158-1165. doi: 10.1378/chest.12-0071.

31.

Patchy deletion of Bmpr1a potentiates proximal pulmonary artery remodeling in mice exposed to chronic hypoxia.

Vanderpool RR, El-Bizri N, Rabinovitch M, Chesler NC.

Biomech Model Mechanobiol. 2013 Jan;12(1):33-42.

32.

Characterization of the isolated, ventilated, and instrumented mouse lung perfused with pulsatile flow.

Vanderpool RR, Chesler NC.

J Vis Exp. 2011 Apr 29;(50). pii: 2690. doi: 10.3791/2690.

33.

Effects of acute Rho kinase inhibition on chronic hypoxia-induced changes in proximal and distal pulmonary arterial structure and function.

Vanderpool RR, Kim AR, Molthen R, Chesler NC.

J Appl Physiol (1985). 2011 Jan;110(1):188-98. doi: 10.1152/japplphysiol.00533.2010. Epub 2010 Nov 18.

34.

Impedance in isolated mouse lungs for the determination of site of action of vasoactive agents and disease.

Vanderpool RR, Naeije R, Chesler NC.

Ann Biomed Eng. 2010 May;38(5):1854-61. doi: 10.1007/s10439-010-9960-2. Epub 2010 Feb 17.

35.

How to measure pulmonary vascular and right ventricular function.

Chesler NC, Roldan A, Vanderpool RR, Naeije R.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:177-80. doi: 10.1109/IEMBS.2009.5333835. Review.

36.

Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships.

Tuchscherer HA, Vanderpool RR, Chesler NC.

J Biomech. 2007;40(5):993-1001. Epub 2006 Jun 6.

PMID:
16756983

Supplemental Content

Loading ...
Support Center